|
| Status |
Public on Nov 18, 2014 |
| Title |
H11A2 |
| Sample type |
RNA |
| |
|
| Source name |
HMLE tumors
|
| Organism |
Homo sapiens |
| Characteristics |
gender: female
cell line: HMLE
genotype/variation: BCL11A overexpression
|
| Treatment protocol |
Overexpression of BCL11A (DOX inducible)
|
| Growth protocol |
HMLE cells were cultrured in HUMEC media prior to injection into NOD-SCID mice
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA from QIAGEN RNA prep kit
|
| Label |
biotin
|
| Label protocol |
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
|
| |
|
| Hybridization protocol |
Standard Illumina hybridization protocol
|
| Scan protocol |
Standard Illumina scanning protocol
|
| Description |
5753685039_D
rep2
|
| Data processing |
All data were normalized and scaled by Partek Genomic Suite 6.4.
|
| |
|
| Submission date |
Nov 18, 2014 |
| Last update date |
Nov 18, 2014 |
| Contact name |
Jack Chen |
| Organization name |
NIH
|
| Street address |
SAIC-Frederick Miller Dr
|
| City |
Frederick |
| State/province |
MD |
| ZIP/Postal code |
21702 |
| Country |
USA |
| |
|
| Platform ID |
GPL10904 |
| Series (1) |
| GSE63386 |
BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells |
|
